What is a stock summary page? Click here for an overview.
Business Description
Exicure Inc
NAICS : 325411
SIC : 2834
ISIN : US30205M1018
Description
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.11 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.88 | |||||
| Debt-to-EBITDA | -0.67 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -13.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 65.2 | |||||
| 3-Year EPS without NRI Growth Rate | 73.9 | |||||
| 3-Year FCF Growth Rate | 71.3 | |||||
| 3-Year Book Growth Rate | -58.3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.78 | |||||
| 9-Day RSI | 63.33 | |||||
| 14-Day RSI | 59.89 | |||||
| 3-1 Month Momentum % | -46.25 | |||||
| 6-1 Month Momentum % | 159.62 | |||||
| 12-1 Month Momentum % | 214.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.45 | |||||
| Quick Ratio | 4.45 | |||||
| Cash Ratio | 4.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -102.6 | |||||
| Shareholder Yield % | -13.53 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -989.8 | |||||
| Net Margin % | -1940.2 | |||||
| FCF Margin % | -582 | |||||
| ROE % | -319.79 | |||||
| ROA % | -82.68 | |||||
| ROIC % | -60.12 | |||||
| 3-Year ROIIC % | -131.66 | |||||
| ROC (Joel Greenblatt) % | -192.93 | |||||
| ROCE % | -111.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 48.41 | |||||
| PB Ratio | 12.45 | |||||
| Price-to-Tangible-Book | 12.49 | |||||
| EV-to-EBIT | -8.45 | |||||
| EV-to-EBITDA | -9.24 | |||||
| EV-to-Revenue | 163.63 | |||||
| EV-to-FCF | -28.11 | |||||
| Price-to-GF-Value | 24.98 | |||||
| Price-to-Net-Current-Asset-Value | 15.72 | |||||
| Price-to-Net-Cash | 19.99 | |||||
| Earnings Yield (Greenblatt) % | -11.83 | |||||
| FCF Yield % | -3.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:XCUR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Exicure Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.5 | ||
| EPS (TTM) ($) | -4.81 | ||
| Beta | 6.24 | ||
| 3-Year Sharpe Ratio | 0.42 | ||
| 3-Year Sortino Ratio | 3.26 | ||
| Volatility % | 886.81 | ||
| 14-Day RSI | 59.89 | ||
| 14-Day ATR ($) | 1.532321 | ||
| 20-Day SMA ($) | 12.559 | ||
| 12-1 Month Momentum % | 214.21 | ||
| 52-Week Range ($) | 1.44 - 36 | ||
| Shares Outstanding (Mil) | 6.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Exicure Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Exicure Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Exicure Inc Frequently Asked Questions
What is Exicure Inc(XCUR)'s stock price today?
The current price of XCUR is $13.99. The 52 week high of XCUR is $36.00 and 52 week low is $1.44.
When is next earnings date of Exicure Inc(XCUR)?
The next earnings date of Exicure Inc(XCUR) is 2025-06-17 Est..
Does Exicure Inc(XCUR) pay dividends? If so, how much?
Exicure Inc(XCUR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers